Prof. Thomas Lynch
Proudly supported by BMS.
Prof. Tony Mok
Tony Mok, MD, is a professor in the Department of Clinical Oncology at the Chinese University of Hong Kong in Prince of Wales Hospital in Hong Kong. His research interests include the application of novel therapeutic approaches in the treatment of lung and liver cancer.
Prof. Mok received his medical degree from the University of Alberta in Canada. His specialty is medical oncology.
Proudly supported by Roche Oncology.
Assoc. Prof Justin Gainor
Justin Gainor, MD, a thoracic oncologist at the Mass General Cancer Center, conducts intensive research on developing novel targeted therapies for patients with genetically-defined forms of lung cancer and designs clinical trials to evaluate these complex, life-saving treatments.
Concurrently, he is delving into the role of the immune system as a means to combat cancer. In recent years, immunotherapies targeting the PD-1 protein have reshaped the management of a number of malignancies. Dr. Gainor is now spearheading Mass General’s clinical trials assessing similar strategies in lung and esophageal cancer. Lastly, he is exploring the intersection of targeted therapies and immunotherapy, both on a clinical and translational level.
Proudly supported by Pfizer Oncology.
Prof. Hisao Asamura
Professor of Surgery, Chief, Division of Thoracic Surgery, Keio University School of Medicine, Tokyo, Japan
Born in Osaka in 1957. Graduated from Keio University School of Medicine in 1983. Internship at the Keio University Hospital and affiliated hospitals (1983-85). Residency in general surgery and Clinical fellow in thoracic surgery at the National Cancer Center Hospital (1986-91). Attending surgeon (Thoracic surgery, 1992-1998), Chief of Thoracic Surgery (1992-2014), and Deputy Director-Hospital (2012-2014) at the National Cancer Center Hospital, Tokyo. Professor of Surgery, Chief, Division of Thoracic Surgery, Keio University School of Medicine (2014-present). Visiting Professor at the Kyorin University in Tokyo (2007-2013) and at the Seoul National University in Seoul, Korea (1999-preseent). Doctor of Medical Science degree from Keio University in 1997.
Chair of Staging Committee (IASLC). Executive Board Director and Chair of the Committee for General Rules of Pathological and Clinical Record for Lung Cancer (Japan Lung Cancer Society). Chair, TNM Committee (Japan UICC Committee) and member of TNM Prognostic Factors Core Group, UICC, Geneva. A Congress President for 58th World Conference on Lung Cancer in Yokohama 2017 by IASLC.
Wittekind C, Asamura H, Sobin LH. TNM Atlas. Wiley Blackwell, 2014.
Asamura H. Asamura’s Operative Thoracic Surgery. Kanehara Co, 2011
Dr José Belderbos
Dr. José Belderbos studied medicine at the University of Utrecht and trained in the field of radiation oncology in Anwerp, Belgium. Since 1994 she worked at the NKI specializing in thoracic oncology. She’s focused on the introduction of new techniques, IMRT, combined modality treatment and optimization of stereotactic image guided radiotherapy for lung cancer. On 28-03- 2007 she obtained her PhD. Her research was supported by the Dutch Cancer Society with several grants.
Assoc. Prof Marianne Davies
Assistant Professor Marianne J. Davies, returned to Yale University with multiple years of graduate teaching experience at YSN, and has been involved at Yale-New Haven Hospital’s Cancer Center since 1983. In the past Davies has worked as an advanced oncology certified nurse. She is currently an acute care nurse practitioner, advanced oncology certified nurse practitioner and clinical nurse specialist in adult health.
She began her nursing education at Russell Sage College in 1983. She continued her education in New Haven, Conn., and received both her Masters and Post Master’s Certificate at YSN. Davies then pursued a Doctorate of Nursing Practice at the MGH Institute of Health Profession in Boston, Mass.
In addition to teaching, Davies has received various awards and honors. She is the recipient of Cogswell Award, Outstanding Student Leadership and Community Involvement, Yale-New Haven Hospital Medical Staff Patient Experience Recognition, the Ruth McCorkle Oncology Advanced Practice Provider: Yale Cancer Center and Nightingale Award for Excellence in Nursing. Davies also belongs to Sigma Theta Tau, the National Honor Society of Nursing, the Connecticut Nurse Practitioner Association, the Oncology Nursing Society and the International Association for the Study of Lung Cancer.